Research highlights citrate's potential as a diagnostic biomarker for SLC13A5-developmental and epileptic encephalopathy. This discovery could enhance early diagnosis and treatment strategies for affected patients.
emerging role of citrate as a diagnostic biomarker in slc13a5 developmental and epileptic encephalopathy
Original title: “The emerging role of citrate as a diagnostic biomarker in SLC13A5-developmental and epileptic encephalopathy.”